Home » Featured » Page 26
Featured
Committee leadership for the U.S. Senate’s Health, Education, Labor and Pensions (HELP) Committee announced that it would provide oversight and investigation of three new areas to improve the nation’s pandemic preparedness effort.
“More than 600,000 Americans have died as a result of... Read More »
With the introduction of new legislation last week, U.S. Rep. Jeff Duncan (R-SC) has proposed the creation of the Office of Policy Development and Cybersecurity (OPDC) within the National Telecommunications and Information Administration (NTIA) to advance national cybersecurity... Read More »
The EB-5 Regional Center program, which is slated to expire June 30, will likely remain temporary now that the U.S. Senate blocked a proposed reauthorization and reform bill.
U.S. Sen. Chuck Grassley (R-IA), ranking member of the U.S. Senate Judiciary Committee, yesterday brought up his EB-5... Read More »
A new report from the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA), a first of its kind known as the AMR Preparedness Index, provides an evaluation and roadmap for the 11 largest global economies and their efforts to tackle rising cases of antimicrobial... Read More »
While Congress continues its debate of President Joe Biden’s proposed $2 trillion American Jobs Plan, 25 medical and healthcare stakeholder organizations are urging the legislators to support the $30 billion the plan would direct to prepare for future pandemics.
In a letter to Congressional... Read More »
A combined supplement from the Centers for Disease Control and Prevention (CDC) and the U.S. Department of Health and Human Services (HHS) last week spread $200 million among 59 jurisdiction public health programs to expand the disease intervention specialists (DIS) workforce.
This funding is... Read More »
With feet to fire, congressional lawmakers are feverishly working to get bipartisan, bicameral companion bills to reauthorize the EB-5 Regional Center Program ready for a U.S. Senate vote before the program’s June 30 expiration date.
There isn’t much time left to get a final bill worked... Read More »
The results of a Johns Hopkins-led study into the potential causes of increased transmission among certain SARS-CoV-2 variants has determined that at least two of these variants showed no evidence of higher viral loads but less likelihood of carriers presenting as asymptomatic.
Utilizing whole... Read More »
Utilizing funds provided for in the American Rescue Plan, the Biden Administration announced last week that it will invest more than $3 billion into the Antiviral Program for Pandemics, promoting the pursuit, development, and manufacturing of antivirals for COVID-19.
That program will be run... Read More »
U.S. Rep. Michael McCaul (R-TX) and Sen. James Risch (R-ID) called on President Joe Biden to immediately impose legally mandated sanctions against the Putin regime in a letter Wednesday.
McCaul, the House Foreign Affairs Committee Lead and Risch, the Ranking Member of the Senate Foreign... Read More »
With acts of domestic terrorism occurring with increasing regularity in the United States, the Biden administration signaled an effort to counter such attacks with the release of the country’s first National Strategy for Countering Domestic Terrorism.
The federal government has provided the... Read More »
Better monitoring of safety measures taken to prevent the spread of infectious diseases by the Transportation Security Administration could prevent the spread of infectious diseases, a new report by the U.S. General Accountability Office (GAO) said.
According to the GAO, while the TSA... Read More »
Proposed congressional legislation would overhaul the Strategic National Stockpile (SNS), expand domestic manufacturing of medical supplies and improve America’s preparedness for public health emergencies.
U.S. Sens. Bill Cassidy (R-LA) and Maggie Hassan (D-NH) on June 8 unveiled the... Read More »
A fourth strong contender appears to have emerged for COVID-19 vaccines in the United States, as this week’s results from the Phase 3 PREVENT-19 trial of the Novavax, Inc. COVID-19 demonstrated a 90 percent overall efficacy against the disease.
The NVX-CoV2373 vaccine fully protected against... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) will provide $706,534 in funding for Dascena, Inc. to further its COViage system, potentially expanding its machine learning capabilities to predict deteriorating health among hospitalized COVID-19 patients.
Hospitalized COVID-19... Read More »
On Wednesday, U.S. Sens. Jeff Merkley (D-OR) and Elizabeth Warren (D-MA) joined U.S. Reps. Raja Krishnamoorthi (D-IL) and Suzanne Bonamici (D-OR) to introduce legislation that would expand the U.S. response to the coronavirus on an international level.
The Nullifying Opportunities for Variants... Read More »
In efforts to improve the Strategic National Stockpile, the U.S. Department of Health and Human Services (HHS) awarded a $53.4 million contract to Henry Schein, Inc. this week for the storage and distribution of 80,000 pallets of personal protective equipment and COVID-19 related products.
This... Read More »
A new study from the Centers for Disease Control and Prevention (CDC) demonstrated continuing good news for mRNA COVID-19 vaccines, crediting them with reducing the risk of infection by 91 percent for those fully vaccinated by either the Pfizer-BioNTech or Moderna vaccines.
While previous... Read More »
In a letter to President Joe Biden last week, more than 40 U.S. representatives sought to use the impending G7 Summit as an opportunity to call for five quick, immediate actions to guarantee COVID-19 vaccines were administered worldwide.
The group, led by U.S. Reps. Pramila Jayapal (D-WA), Tom... Read More »
The newest White House budget proposal would put billions of dollars in funding toward public health, drug, and research initiatives, offering what the Infectious Diseases Society of America (IDSA) called the potential to return the United States to leadership in infectious disease responses.
At... Read More »
With $4.2 million in funding from the Henry Jackson Foundation and a new partnership with the U.S. Naval Medical Research Center (NMRC), Centivax Inc. intends to pursue phase one clinical development of Centi-B9, a broad-spectrum injectable for treating SARS-CoV-2.
Unlike other vaccines and... Read More »
The leaders of the international organizations for financing, health, and trade are urging government leaders to finance a new $50 billion roadmap to help end the pandemic and spur global economic recovery.
Leaders of the International Monetary Fund, World Bank Group, World Health Organization,... Read More »
U.S. Reps. Brian Fitzpatrick (R-PA) and Conor Lamb (D-PA) sought legislative action on foreign nations’ health efforts last week, introducing the Never Again International Outbreak Prevention Act to establish new monitoring and reporting mandates, sanctions, and an investigation of the World... Read More »
President Joe Biden’s first budget proposal would authorize the largest funding increase in nearly two decades for the Centers for Disease Control and Prevention (CDC), going above and beyond funding the agency’s disease-focused work at the U.S. Department of Health and Human Services... Read More »
According to the World Health Organization (WHO), the COVID-19 pandemic situation is stabilizing in nations with advanced vaccination programs, but it is surging in other, less equipped areas, demanding action lest the future become a repeat of present failures.
WHO urges the distribution of 2... Read More »
The U.S. Food and Drug Administration (FDA) added another tool to the fight against COVID-19 this week, granting emergency use authorization (EUA) to the monoclonal antibody therapy sotrovimab for use against mild to moderate COVID-19 cases in those 12 years and older.
The EUA was granted to... Read More »
Thanks to a $400,000 grant from The Rockefeller Foundation, the Johns Hopkins Center for Health Security will document, evaluate and spread information on large-scale health successes among the COVID-19 response in low and middle-income nations over the past year.
This information will be used... Read More »
Academia and the private sector must be in a collaborative relationship with the United States government to invest in the research and development of technologies that will prevent a future pandemic, experts said on Wednesday during a webinar hosted by the Capitol Hill Steering Committee on... Read More »
Plans are underway to submit the Moderna, Inc. COVID-19 vaccine to regulators in early June to expand its use, following positive results from a Phase 2/3 study that distributed the vaccine among adolescents aged 12 to 17 years old.
The vaccine, known as mRNA-1273, met its primary immunogenicity... Read More »
In a letter to Homeland Security Secretary Alejandro Mayorkas written last week, Republican House Energy and Commerce Committee leaders requested two classified briefings on the origins of COVID-19 and any work conducted therein.
“[W]e strongly support a comprehensive investigation into the... Read More »
With the reintroduction of the Medical Supplies for Pandemics Act in the Senate last week, U.S. Sens. Thom Tillis (R-NC) and Michael Bennet (D-CO) sought to more tightly link the federal government and medical product distributors to strengthen domestic manufacturing and refill the Strategic... Read More »
In the wake of a pandemic response that had been hobbled initially by a lack of domestic medical supplies and an overreliance on foreign supply chains, Senate Homeland Security and Governmental Affairs Committee Chairman Gary Peters (D-MI) held an oversight hearing with supply chain,... Read More »
Up to $4.1 million in non-dilutive funding from nonprofit CARB-X was announced this week for Summit Therapeutics to help develop a first-in-class antibiotic to treat multidrug-resistant infections, and specifically, carbapenem-resistant Enterobacteriaceae (CRE) infections.
This funding will aid... Read More »
Across all adult age groups, going as high as 95 years old, a phase two trial of the Sanofi and GSK adjuvanted recombinant COVID-19 vaccine candidate has demonstrated high antibody responses and no safety concerns, according to interim data released this week.
Strong immune responses included a... Read More »
The Defense Logistics Agency (DLA) recently awarded a $100,000 contract to Charles River Analytics for the creation of a means to assemble information from global trade networks and pharmaceutical drug data and present it in a way that would allow quick identification of problems in the supply... Read More »
